Table I.
Characteristics of included studies
Study | Country | No. of samples | Gender (male,%) | Age, mean [years] | BMI, mean [kg/m2] | Study design | Diagnostic method of OSA | OSA category (AHI or RDI) | Nocturnal IH category (ODI or CT90) | MS criteria |
---|---|---|---|---|---|---|---|---|---|---|
Coughlin et al. 2004 | UK | 104 | All were male | 49.6 | 33.5 | Hospital-based Cross-sectional | Standard PSG | OSA ≥ 15 Non-OSA ≤ 15 | N/A | NCEP ATPIII |
Sasanabe et al. (male) 2006 | Japan | 778 | All were male | 47.9 | 27.4 | Hospital-based Cross-sectional | Standard PSG | OSA ≥ 15 Non-OSA ≤ 5 | N/A | Japanese criteria |
Sasanabe et al. (female) 2006 | Japan | 130 | All were female | 51.9 | 26.9 | Hospital-based Cross-sectional | Standard PSG | OSA ≥ 15 Non-OSA ≤ 5 | N/A | Japanese criteria |
Gruber et al. 2006 | UK | 79 | N/A | 47.3 | 33.3 | Hospital-based Cross-sectional | Standard PSG | OSA ≥ 5 Non-OSA ≤ 5 | N/A | IDF guidelines |
Nieto et al. 2009 | USA | 546 | 56 | 59.9 | 31.1 | Population-based Cross-sectional | Standard PSG | OSA ≥ 15 or CPAP Non-OSA ≤ 5 | N/A | NCEP ATPIII |
Chin et al. 2010 | Japan | 275 | All were male | 44 | 23.9 | Population-based Cross-sectional |
Portable PSG | OSA ≥ 5 Non-OSA ≤ 5 |
N/A | NCEP ATPIII |
Muraki et al. (male) 2010 | Japan | 1710 | All were male | 58 | 24 | Population-based Cross-sectional | Pulse-oximetry | N/A | ODI ≥ 5 vs. ODI < 5 | NCEP ATPIII |
Muraki et al. (female) 2010 | Japan | 2896 | All were female | 56.5 | 23.3 | Population-based Cross-sectional | Pulse-oximetry | N/A | ODI ≥ 5 vs. ODI < 5 | NCEP ATPIII |
Troxel et al. 2010 | USA | 290 | N/A | N/A | N/A | Population-based Case-control | Portable PSG | As continuous variable | N/A | NCEP ATPIII |
Theorell et al. 2011 | Sweden | 400 | All were female | 50.1 | 26.7 | Population-based Cross-sectional | Standard PSG | As continuous variable | ODI and CT90 as continuous variables | NCEP ATPIII |
Gasa et al. 2011 | Spain | 159 | 44.5 | 43 | 46.1 | Hospital-based Cross-sectional | Standard PSG | OSA ≥ 15Non-OSA ≤ 15 | CT90 ≥ 4.65% of TST vs. CT90 < 4.65% of TST | NCEP ATPIII |
Agrawal et al. 2012 | India | 227 | 78.4 | 45.2 | 32 | Hospital-based Case-control | Standard PSG | N/A | CT90 as continuous variable | NCEP ATPIII |
Hall et al. 2012 | USA | 340 | All were female | 51.2 | 29.8 | Population-based Case-control | Standard PSG | As continuous variable | N/A | NCEP ATPIII |
OSA – obstructive sleep apnea, MS – metabolic syndrome, PSG – polysomnography, AHI – apnea hypopnea index, RDI – respiratory disturbance index, IH – intermittent hypoxia, ODI – oxygen desaturation index, CT90 – cumulative percentage of sleep time with SpO2 below 90%, TST – total sleep time, NCEP ATPIII – National Cholesterol Education Program Adult Treatment Panel III, IDF – International Diabetes Federation, N/A – not available.